The Translational Research Centre in Onco-Hematology (CRTOH), created in 2017, is dedicated to promoting translational and interdisciplinary cancer research that has the potential to quickly benefit patients. This involves a close collaboration between clinicians and researchers, and a proximity with the patients. The Centre also aims to promote the training of the next generation of researchers and clinicians focusing on translational cancer research.

The CRTOH comprises 31 research groups, including around 300 collaborators. Our ongoing research efforts are centered around several key areas, including tumor immunology and immunotherapy, precision oncology, cell division and cancer, and cancer pharmacology. Since 2022, the CRTOH is coordinated by Professors Mikael Pittet and Olivier Michielin.